Abstract
Autism Spectrum Disorders (ASD) are characterized by dysfunction in three core symptom domains: social impairments, communication impairments, and repetitive behaviours with restricted interests. Oxytocin (OXT) and the structurally similar peptide arginine vasopressin (AVP), may play a role in the etiology of these disorders, especially in the social difficulties domain. Oxytocin is involved in milk let-down and uterine contractions at a peripheral level, while in the brain it predominantly has a neuromodulatory function on affiliative and social behavior. Abnormalities of OXT in ASD are herein reviewed, using blood studies, neuroimaging, and translational research. Genetic abnormalities in OXT have also been consistently reported in ASD. Clinical trials with OXT are currently aimed at reducing social impairments and repetitive behaviours. Finally, the current limitations and prospects for the future of OXT treatment in ASD are discussed.
Keywords: Autism spectrum disorders, social behaviour, oxytocin, arginine vasopressin, translational research, therapeutics, prohormone, endogenous, Vineland Adaptive Behavior Scales, ADP-ribosyl, cyclase activity, neuroimaging, neuromodulatory, arginine vasopressin (AVP), uterine
Current Psychopharmacology
Title: The Role of Oxytocin in Autism Spectrum Disorders
Volume: 1
Author(s): Roberto Canitano and Valeria Scandurra
Affiliation:
Keywords: Autism spectrum disorders, social behaviour, oxytocin, arginine vasopressin, translational research, therapeutics, prohormone, endogenous, Vineland Adaptive Behavior Scales, ADP-ribosyl, cyclase activity, neuroimaging, neuromodulatory, arginine vasopressin (AVP), uterine
Abstract: Autism Spectrum Disorders (ASD) are characterized by dysfunction in three core symptom domains: social impairments, communication impairments, and repetitive behaviours with restricted interests. Oxytocin (OXT) and the structurally similar peptide arginine vasopressin (AVP), may play a role in the etiology of these disorders, especially in the social difficulties domain. Oxytocin is involved in milk let-down and uterine contractions at a peripheral level, while in the brain it predominantly has a neuromodulatory function on affiliative and social behavior. Abnormalities of OXT in ASD are herein reviewed, using blood studies, neuroimaging, and translational research. Genetic abnormalities in OXT have also been consistently reported in ASD. Clinical trials with OXT are currently aimed at reducing social impairments and repetitive behaviours. Finally, the current limitations and prospects for the future of OXT treatment in ASD are discussed.
Export Options
About this article
Cite this article as:
Canitano Roberto and Scandurra Valeria, The Role of Oxytocin in Autism Spectrum Disorders, Current Psychopharmacology 2012; 1 (2) . https://dx.doi.org/10.2174/2211556011201020178
DOI https://dx.doi.org/10.2174/2211556011201020178 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Dendritic Cell-T Cell Synapse as a Determinant of Autoimmune Pathogenesis
Current Pharmaceutical Design Recent Pharmacoproteomics Studies of Warfarin in the Asia-Pacific: A New Strategy for Personalized Medicine?
Current Pharmacogenomics and Personalized Medicine Meet Our Editorial Board Member
Current Medical Imaging TNF-α and Ghrelin: Opposite Effects on Immune System, Metabolism and Mental Health
Protein & Peptide Letters New Targeted Therapies for Thyroid Cancer
Current Genomics Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Sepsis, Coagulation and Anticoagulants
Endocrine, Metabolic & Immune Disorders - Drug Targets Diagnosis of Alterations of Serum Calcium Metabolism
Medicinal Chemistry Physical Activity Level and Motor Aptitude: Motor Domains and Identification Capacity of Brazilian Insufficiently Active Older Adults
Current Aging Science Spectroscopic and Functional Characterization of Human β-Synuclein
Protein & Peptide Letters Interference of Metals and Medications with the Detection of Lipid Peroxidation in Humans by Photometric TBARS Assay
Current Analytical Chemistry ‘Non-Criteria’ Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered
CNS & Neurological Disorders - Drug Targets The Therapeutic Potential of Adenosine Triphosphate as an Immune Modulator in the Treatment of HIV/AIDS: A Combination Approach with HAART
Current HIV Research The Start of a New Era for Stroke Treatment: Mechanical Thrombectomy Devices
Current Neurovascular Research Molecular Classification and Drug Response Prediction in Cancer
Current Drug Targets Pathophysiology and Treatment of Fibromyalgia Syndrome
Current Rheumatology Reviews Differentiation-Inducing Therapy for Solid Tumors
Current Pharmaceutical Design Development of Hypoxia Selective Cytotoxins for Cancer Treatment: An Update
Medicinal Chemistry Astaxanthin; a Promising Protector Against Gentamicin-Induced Nephrotoxicity in Rats
Current Pharmaceutical Biotechnology Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis
Inflammation & Allergy - Drug Targets (Discontinued)